Thompson Hine advised Vaxart, while Paul Hastings LLP advised Oppenheimer & Co. as the sole bookrunner in the offering. Vaxart, Inc. (Nasdaq: VXRT) announced an underwritten...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here